U.S. Gives Green Light to Publish Controversial Bird Flu Research

powered by healthline

Average Ratings

After expert panel review, officials say H5N1 findings are of benefit, with little risk to national security

FRIDAY, April 20 (HealthDay News) -- The U.S. government is giving the go-ahead for publication of two controversial studies into the H5N1 avian (bird) flu virus, a top federal health official announced Friday.

The research, led by two scientists -- Yoshihiro Kawaoka of the University of Wisconsin and Ron Fouchier of Erasmus Medical Center in Rotterdam, the Netherlands -- involved the manipulation of the potentially lethal virus until it was transmissible between ferrets, thought to be a close model for humans. As yet, H5N1 is not easily transmitted between humans.

In December, the Department of Health and Human Services (HHS) requested that two leading journals, Science and Nature, censor some of the data from this research for national security reasons. The concern was that terrorists might use the information to create a biological weapon.

However, on Friday, Dr. Francis Collins, director of the U.S. National Institutes of Health, announced in a statement that full publication could go forward. The decision was based on a March 29-30 meeting of the National Science Advisory Board for Biosecurity (NSABB), an independent panel of experts that advises the federal government on such matters.

According to Collins, "After careful deliberation, the NSABB unanimously recommended the revised manuscript by Dr. Yoshihiro Kawaoka be communicated in full. The NSABB also recommended, in a 12-to-6 decision, that the data, methods, and conclusions presented in the revised manuscript by Dr. Ron Fouchier be communicated fully after a number of further scientific clarifications are made in the manuscript."

Collins added that the research has "direct applicability to ongoing and future influenza surveillance efforts and does not appear to enable direct misuse of the research in ways that would endanger public health or national security."

He said that HHS Secretary Kathleen Sebelius agreed with the decision. "The information in the two manuscripts should be communicated fully and we have conveyed our concurrence to the journals considering publication of the manuscripts," Collins said.

Kathy Wren, a spokeswoman for Science, which is withholding the Fouchier study, said the journal is still waiting for a decision by Dutch regulators next week before deciding when it will publish the research, Bloomberg News reported.

More information

Find out more about H5N1 avian influenza at the U.S. Centers for Disease Control and Prevention.


-- E.J. Mundell
Copyright © 2012 HealthDay. All rights reserved.
Article from
Top of page
General Drug Tools
General Drug Tools view all tools
Tools for
Healthy Living
Tools for Healthy Living view all tools
Search Tools
Search Tools view all tools
Insurance Plan Tools
Insurance Plan Tools view all tools

What is a reference number?

When you register on this site, you are assigned a reference number. This number contains your profile information and helps UnitedHealthcare identify you when you come back to the site.

If you searched for a plan on this site in a previous session, you might already have a reference number. This number will contain any information you saved about plans and prescription drugs. To use that reference number, click on the "Change or view saved information" link below.

You can retrieve information from previous visits to this site, such as saved drug lists and Plan Selector information.